Carl Zeiss: Significant Underperformance, Valuation At Multi-Year Lows [Seeking Alpha]
CARL ZEISS MEDI UNSP/ADR (CZMWY)
NASDAQ:AMEX Investor Relations:
zeiss.com/meditec-ag/investor-relations.html
Company Research
Source: Seeking Alpha
Follow Summary Carl Zeiss Meditec has seen a 30%+ decline due to earnings and margin drops, but remains a strong market leader with significant long-term upside. Despite current underperformance, the company's strategic R&D investments and growing recurring revenue position it well for future recovery and growth. The company's valuation has dipped, but I believe it offers a compelling long-term upside, with potential annualized returns of 15-30%. I maintain a "buy" rating with a price target of €130/share, emphasizing the importance of long-term investment and market normalization. JHVEPhoto Dear readers/followers, I was honestly surprised when I saw the degree of underperformance in Carl Zeiss ( OTCPK:CZMWF OTCPK:CZMWY ), a small position I have been increasing step by step over the past few months and about a year of underperformance where the company has greatly normalized in valuation. This is one of the issues of investing in and even covering companies that tend
Show less
Read more
Impact Snapshot
Event Time:
CZMWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CZMWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CZMWY alerts
High impacting CARL ZEISS MEDI UNSP/ADR news events
Weekly update
A roundup of the hottest topics
CZMWY
News
- Global Vitrectomy Devices Market Size Projected to Grow to USD 1.89 Billion by 2032, with a CAGR of 5.28% - S&S Insider [Yahoo! Finance]Yahoo! Finance
- Carl Zeiss Meditec (ETR:AFX) Will Be Hoping To Turn Its Returns On Capital Around [Yahoo! Finance]Yahoo! Finance
- Is Carl Zeiss Meditec AG's (ETR:AFX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? [Yahoo! Finance]Yahoo! Finance
- ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutionsPR Newswire
- ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutionsPR Newswire